Med Tech industry

Optimize your business decisions with our best-in-class overview of reimbursement status and strategy for medical devices in Europe

Our two core services are the provision of off-the-shelf and on-demand reimbursement analysis and the development of reimbursement strategy for medical devices in 18 European countries

Analysis

Reimbursement

  • Availability of procedure / reimbursement code
  • Reimbursement mechanism (diagnosis-related group or fee for service)
  • Availability of add-on reimbursement
  • Availability of innovation funding
  • Reimbursement tariffs

National funding

Willingness to pay for technology, based on:

  • Statements from national commissioners (e.g., NHS England)
  • Health Benefit Catalogues (e.g. in Spain, LEA Levels in Italy)
  • National clinical guidance (e.g. NICE in the UK, Haute Autorité de Santé in France, Socialstyrelsen in Sweden)
  • National health technology assessments in connection with reimbursement decisions (e.g. NICE for Technology Appraisal in the UK, Haute Autorité de Santé in France)
  • Specific funding frameworks (e.g., “New method” in Norway)
Strategy

Reimbursement strategy

Pathway to get reimbursement:

  • Overview of drivers and barriers for adoption
  • Overview of key reimbursement and funding pathways (including state-sponsored studies and innovation funding)
  • Detailed presentation of individual pathways (process, stakeholders, requirements, timelines)
  • Action plan

We tailor our services to fit your requirements and budget

Our solutions vary from low cost off-the-shelf EU reimbursement reports for dozens of technologies to customized reimbursement mapping, evidence and reimbursement strategy projects. Contact us to determine the most optimal solution for your business decisions

Our services cover 18 European countries, including Austria, Belgium, Czech Republic, Denmark, England, Finland, France, Germany, Hungary, Italy, the Netherlands, Norway, Poland, Romania, Russia, Spain, Sweden and Switzerland

We provide services for major types of medical technologies

Implantable devices

Interventional procedures

Non-in­ter­ven­tional procedures

Medical aids

Our analytical team has worked on hundreds of reimbursement projects within different clinical and technological areas, including heart valve replacement, minimally invasive and open heart surgery, coronary, cerebral and peripheral stenting, coronary diagnostic and imaging techniques (fractional flow reserve, intravascular ultrasound), coronary, cerebral and peripheral vascular thrombectomy, implantable and extracorporeal ventricular assist devices, clinic- and home-based dialysis, extracorporeal membrane oxygenation, apheresis, obesity surgery, hernia and reconstruction surgery, tissue products and skin reconstruction surgery, negative wound pressure therapy and medical bandages, neurostimulators for different indications, cell therapy, rehabilitation devices, devices for minimally invasive and open spine surgery, embolization procedures, glucose monitoring, use of fusidial markers, radiotherapy, endoscopy and more

Check out our database of the off-the-shelf reimbursement reports for medical technologies in 11 European countries

Released reports:

  • 3D conformal radiation therapy
  • Ablation of heart tissue for atrial fibrillation
  • Angioplasty of arteries of lower extremities for peripheral artery disease
  • Atherectomy for peripheral artery disease
  • Brachytherapy
  • Combined report for minimally invasive and transcatheter mitral valve repair and replacement procedures for mitral regurgitation
  • Coronary imaging and diagnostic procedures
  • Coronary percutaneous revascularization procedures
  • Extra-corporeal membrane oxygenation (ECMO) for pulmonary and cardiac failure
  • Image-guided radiotherapy
  • Intensity modulated radiotherapy (IMRT)
  • Mechanical thrombectomy for acute ischemic stroke
  • Minimally-invasive mitral valve repair with creation of artificial chordae tendonae for mitral regurgitation
  • Minimally-invasive replacement of mitral valve for mitral regurgitation
  • Minimally-invasive reshaping of heart geometry for mitral regurgitation
  • Percutaneous ablation procedures for diseases of lung, prostate, kidney, liver and bone
  • Percutaneous procedures for deep vein thrombosis
  • Proton Therapy
  • Robotic surgery interventions
  • Spinal cord stimulation
  • Stereotactic body radiation therapy
  • Stereotactic Radiosurgery
  • Surgical and endovascular treatment of brain aneurysm
  • Transcatheter annuloplasty ring for mitral regurgitation
  • Transcatheter aortic valve implantation (TAVI)
  • Transcatheter mitral annuloplasty using implant placed in the coronary sinus for mitral regurgitation
  • Transcatheter mitral valve leaflet repair using mitral clips for mitral regurgitation
  • Transcatheter mitral valve repair using mitral annulus plication for mitral regurgitation
  • Transcatheter mitral valve replacement
  • Vascular access for long-term use: AV fistula and AV graft
  • Ventricular assist devices for circulatory support
  • Volumetric modulated arc therapy (VMAT)

Ongoing reports:

  • Balloon sinus dilation for chronic sinusitis
  • Bariatric surgery
  • Capsule endoscopy
  • Cardiac pacemakers
  • Cardiac resynchronization therapy
  • Computed tomography in ambulatory settings
  • Cochlear implants for hearing loss
  • Deep brain stimulation
  • Endovascular repair (EVAR) of abdominal aortic aneurysm (AAA)
  • Gastric electrical stimulation for gastroparesis and obesity
  • Hernia repair
  • Hospital and out-patient remote monitoring coding and reimbursement for neurostimulators
  • Implantable cardioverter defibrillators (ICDs)
  • Inferior Vena Cava Filter
  • Lung volume reduction for emphysema
  • Magnetic resonance imaging in ambulatory settings
  • Minimally invasive endoluminal procedures for gastro-esophageal reflux disease (GERD)
  • Open replacement of heart valves (all valves)
  • Peripheral intravascular ultrasound
  • Vagus nerve stimulation

Confidence in results

We have established numerous procedures and services to ensure the high relevance and precision of our analysis in order to successfully guide your business decisions:

  • Standard Operating Procedures and Work Instructions
  • Access to official coding and DRG manuals, tariff lists and grouping software
  • A team comprised of experienced Clinical Coders with a medical background
  • Quick access to health authorities to address uncertainties
  • Ongoing research program to get insights from payer and provider interviews
  • All reports are reviewed by the CEO before release

Get analysis results within weeks

  • Our standard turnaround time for on-demand services is 4-5 weeks for reimbursement analysis and an additional 3-4 weeks for strategy
  • You can request an "express delivery" option, if you need an analysis within 2 weeks
  • Off-the-shelf reimbursement reports are delivered immediately after payment is processed

Are you interested in learning more about how we can help you?